Back

Prognostic value of the MAGGIC score and right ventricular echocardiographic parameters in HFrEF

18 May 2025 (13:00 - 14:20)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - epidemiology, prognosis, outcome (2) Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Emmanuelle Berthelot

Hopital Bicetre, Le Kremlin-Bicetre (France)

5 More presentations in this session

Presentation thumbnail
Acute coronary syndrome in young women: risk factors and long-term prognosis
Doctor L. Brochado (Almada, PT)
Abstract Slides Video
Presentation thumbnail
DIAMETER score and its relationship with long-term mortality in heart failure patients with reduced ejection fraction, a novel score
Associate Professor B. MURAT (Eskisehir, TR)
Abstract Slides Video
Presentation thumbnail
The impact of body mass index on the survival of heart failure patients with impaired systolic function undergoing percutaneous coronary intervention. does the obesity paradox exist?
Doctor A. Ceka (Tirana, AL)
Abstract Slides Video
Presentation thumbnail
Prognostic implications of renal function trajectories in heart failure management
Doctor A. Koh (Kuching, MY)
Abstract Slides Video
Presentation thumbnail
Clinical profile and outcomes of patients hospitalized with heart failure
Doctor L. Ferhatbegovic (Zenica, BA)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - epidemiology, prognosis, outcome (2)

The Event

Event poster

Heart Failure 2025

18 May 2025 13:00 CET
You may be interested in
thumbnail
Congress Presentation
Right ventricular to pulmonary artery coupling is the best predictor of the outcome in patients with heart failure with reduced ejection fraction and secondary mitral regurgitation
thumbnail
Congress Presentation
Echocardiographic characteristics of patients with CpcPH, and IpcPH in HFrEF, Insight of PHHF study. Insight of PHHF study
thumbnail
Congress Presentation
TAPSE/sPAP by echocardiography to detect elevated pulmonary vascular resistance> 4 WU in postcapillary pulmonary hypertension patients: insights from the French PH HF registry

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources